Cargando…

Protocol for the development of a reporting guideline for clinical trials with integrated Chinese and western medicine interventions: the CONSORT extension for ICWM

BACKGROUND: While Integrated Chinese and Western Medicine (ICWM) has become widely accepted as a necessary intervention for treating various diseases, key information about ICWM interventions is often missing in published clinical trials. To facilitate complete, transparent, and consistent reporting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Juan, Zhang, Xuan, Wang, Ping, Han, Fei, Li, Ji, Ma, Yanfang, Lyu, Aiping, Bian, Zhaoxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344360/ https://www.ncbi.nlm.nih.gov/pubmed/37457590 http://dx.doi.org/10.3389/fmed.2023.1190560

Ejemplares similares

Protocol of the CONSORT and SPIRIT Extension for multicenter clinical trials
por: Zhang, Xuan, et al.
Publicado: (2023)

A Comparative Study for License Application Regulations on Proprietary Chinese Medicines in Hong Kong and Canada
por: Zhong, Linda L. D., et al.
Publicado: (2021)

Standards for reporting interventions in clinical trials of cupping (STRICTOC): extending the CONSORT statement
por: Zhang, Xuan, et al.
Publicado: (2020)

Reporting quality of randomized controlled trials of angina pectoris with integrated traditional Chinese and western medicine interventions: a cross-sectional study
por: Deng, Jiashuai, et al.
Publicado: (2023)

Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries
por: Zhang, Xuan, et al.
Publicado: (2019)

Protocol for CONSORT-SPI: an extension for social and psychological interventions
por: Montgomery, Paul, et al.
Publicado: (2013)

Enhanced Evidence-Based Chinese Medicine Clinical Practice Guidelines in Hong Kong: A Study Protocol for Three Common Diseases
por: Shi, Nannan, et al.
Publicado: (2015)

A national survey of Chinese medicine doctors and clinical practice guidelines in China
por: Liu, Mengyu, et al.
Publicado: (2017)

P05.50. CONSORT extension for N-of-1 trials (CENT) guidelines
por: Shamseer, L, et al.
Publicado: (2012)

Reporting guidelines for health care simulation research: extensions to the CONSORT and STROBE statements
por: Cheng, Adam, et al.
Publicado: (2016)

Evidence-based Chinese Medicine Clinical Practice Guideline for Stroke in Hong Kong
por: Zhong, Linda L. D., et al.
Publicado: (2020)

Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

Hong Kong Chinese Medicine Clinical Practice Guideline for Cancer Palliative Care: Pain, Constipation, and Insomnia
por: Lam, Wai Ching, et al.
Publicado: (2019)

Placebo design in WHO-registered trials of Chinese herbal medicine need improvements
por: Zhang, Xuan, et al.
Publicado: (2019)

Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension
por: Liu, Xiaoxuan, et al.
Publicado: (2020)

Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension
por: Liu, Xiaoxuan, et al.
Publicado: (2020)

A cross-sectional study of the endorsement proportion of reporting guidelines in 1039 Chinese medical journals
por: Duan, Yuting, et al.
Publicado: (2023)

Implications of the artificial intelligence extensions to the guidelines for consolidated standards of reporting trials and for standard protocol item recommendations for interventional trials (the CONSORT-AI and SPIRIT-AI extensions)
por: Solebo, Ameenat Lola, et al.
Publicado: (2020)

Assessment of the quality of reporting in randomised controlled trials of acupuncture in the Korean literature using the CONSORT statement and STRICTA guidelines
por: Kim, Kun Hyung, et al.
Publicado: (2014)

Development of a core outcome set on Traditional Chinese Medicine and Western Medicine for rheumatic heart disease: a study protocol
por: Sheng, Xiaodi, et al.
Publicado: (2022)

Improving the reporting of pragmatic trials: an extension of the CONSORT statement
por: Zwarenstein, Merrick, et al.
Publicado: (2008)

CONSORT 2010 statement: extension to randomised crossover trials
por: Dwan, Kerry, et al.
Publicado: (2019)

Initial observations of Jinhua Qinggan Granules, a Chinese medicine, in the mitigation of hospitalization and mortality in high-risk elderly with COVID-19 infection: A retrospective study in an old age home in Hong Kong
por: Lin, Timothy P. H., et al.
Publicado: (2022)

Editorial: Artificial Intelligence (AI) in Clinical Medicine and the 2020 CONSORT-AI Study Guidelines
por: Parums, Dinah V.
Publicado: (2021)

IJD(®): Consorting with CONSORT 2010
por: Panda, Saumya, et al.
Publicado: (2013)

Development of a Core Outcome Set for the Benefits and Adverse Events of Acute Heart Failure in Clinical Trials of Traditional Chinese Medicine and Western Medicine: A Study Protocol
por: Qiu, Ruijin, et al.
Publicado: (2021)

Developing TCM clinical practice guidelines: A comparison between traditional Chinese medicine and western medicine
por: Yu, Xuan, et al.
Publicado: (2023)

Traditional Chinese medicine for irritable bowel syndrome: from classic formula to modern medicine development
por: Bian, Zhaoxiang
Publicado: (2012)

Editorial: Standards of Reporting: The CONSORT, QUORUM, and STROBE Guidelines
por: Brand, Richard A.
Publicado: (2009)

Reporting of randomized controlled trials as per CONSORT guidelines
por: Misra, Puneet, et al.
Publicado: (2022)

Protocol for the development of a CONSORT extension for RCTs using cohorts and routinely collected health data
por: Kwakkenbos, Linda, et al.
Publicado: (2018)

Guidelines for the diagnosis and treatment of knee osteoarthritis with integrative medicine based on traditional Chinese medicine
por: Zeng, Lingfeng, et al.
Publicado: (2023)

Combination of Chinese herbal medicine and conventional western medicine for coronavirus disease 2019: a systematic review and meta-analysis
por: Tong, Lei, et al.
Publicado: (2023)

CONSORT 2010 statement: extension to randomised pilot and feasibility trials
por: Eldridge, Sandra M., et al.
Publicado: (2016)

CONSORT 2010 statement: extension to randomised pilot and feasibility trials
por: Eldridge, Sandra M, et al.
Publicado: (2016)

Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trials
por: Welch, Vivian, et al.
Publicado: (2015)

Editorial: Family medicine and primary care: Best practice to achieve health equity for western and traditional Chinese medicine
por: Xiong, Xiaomo, et al.
Publicado: (2023)

Expert consensus and operational guidelines on exercise rehabilitation of chronic obstructive pulmonary disease with integrating traditional Chinese medicine and Western medicine
por: Chen, Xuan, et al.
Publicado: (2021)

SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol
por: Espinasse, Aude, et al.
Publicado: (2023)

CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_elumd0srl3mtu7e5usph600qsl